About: fang

HONG KONG, May 16, 2025 - (ACN Newswire via SeaPRwire.com) – The Payment Cards Group Limited (“PCG”), a cloud-native payment processor and acquirer, and its members achieved multiple milestones in April this year, actively empowering Hong Kong's innovation and technology sector as well as its mega-event economy through innovative payment technologies. BBMSL, the payment solutions provider under PCG, was honored as “Best Digital Payment Service Provider” at the EDigest Brand Awards 2025. PCG’s digital payment acceptance business, Yedpay, continued to support various local mega events, including the Tsing Yi Bamboo Theater 2025 and the Cathay/HSBC Hong Kong Sevens 2025. Meanwhile, PCG’s startup business, A3A, Asia’s first cloud-based processing and settlement platform, was invited to participate in InnoEX 2025 and the Hong Kong ICT Awards (FinTech) 2024 Post-Award Networking Event.BBMSL pioneers digital payment innovation, garnering industry recognitionSince officially joining the PCG Group in December 2024, BBMSL has continuously driven innovative development within the local payment ecosystem. Guided by its “Payment Beyond Imagination” philosophy and “Merchant-First” strategy, BBMSL was recently honored as “Best Digital Payment Service Provider” by EDigest at the EDigest Brand Awards 2025, affirming BBMSL’s exceptional contributions in providing innovative, secure payment solutions to small and medium-sized enterprises (SMEs). In terms of industry events, PCG was one of the Gold Sponsors at the GS1 Hong Kong Annual Members Dinner held on April 8. BBMSL represented PCG at the event, showcasing the latest digital payment solutions and engaging with over 500 industry leaders to explore collaboration opportunities. Additionally, on April 13, BBMSL was one of the supporting organizations for the IOT Data Hackathon 2025 Awards Ceremony at InnoEX 2025, witnessing young industry talent leverage IoT data to create innovative solutions for smart business and smart living. Recently, BBMSL was featured in an article by Capital HK, highlighting how the strategic integration between PCG and BBMSL is reshaping the payment ecosystem. Through the integration with A3A, BBMSL has successfully increased payment efficiency by 25%, while leveraging PCG’s status as a card scheme-recognized acquirer to optimize processes and enhance fund security. Looking ahead, BBMSL and PCG will continue to collaborate closely to advance digital payment development in Hong Kong and usher in a new phase of comprehensive service. For the full article, please visit: https://www.capital-hk.com/column/blogger-AvyYu-20250424Yedpay supports mega-event economy, promoting a cashless societyYedpay has continued to promote a cashless society in Hong Kong and has recently successfully supported several local mega events, which showcased the diverse applications of digital payment technology. For sporting events, Yedpay provided digital payment services for the Cathay/HSBC Hong Kong Sevens 2025 from March 28 to 30, which allowed spectators to experience smooth cashless transactions. In terms of cultural activities, Yedpay provided a full range of digital payment services for the activity booths at the Tsing Yi Bamboo Theater 2025 from April 9 to 13, including POS terminals and QR code payment solutions, which enabled citizens and tourists to enjoy the convenience of modern payment technology while experiencing the traditional bamboo theater culture. Additionally, Yedpay provided digital payment services at the Coldplay and Nicholas Tse concerts held in April, which enabled fans to enjoy instant transactions and contributing to Hong Kong’s development as a smart city.A3A was invited to participate in InnoEX 2025 and the Hong Kong ICT Awards (FinTech) 2024 Post-Award Networking EventThanks to its innovative financial cloud solutions, A3A, a member of PCG, was awarded the “Hong Kong ICT Awards 2024: FinTech Award” last year. In April this year, A3A was invited to join two major innovation and technology events, demonstrating its leadership in the payment technology industry.At InnoEX 2025, held from April 13 to 16, A3A was invited by Hong Kong’s Digital Policy Office (DPO) to showcase its award-winning payment processing innovations and future developments. During the exhibition, the A3A team engaged in insightful conversations with numerous industry experts to explore future trends in payment technology and establish valuable cooperative relationships. In the same month, A3A was invited by the Institute of Financial Technologists of Asia (IFTA) to attend the Hong Kong ICT Awards (FinTech) 2025 Kick-off Briefing & 2024 Post-Award Networking Event. During the event, the A3A team shared its strategic directions, including how A3A is redefining digital payments and secure data ecosystems, along with its plan to accelerate growth and adoption of its cloud payment processing platform. These key participations not only showcase PCG’s technological capability, but also lay a solid foundation for future development. Moving forward, PCG will continue to collaborate with its enterprise members to enhance payment solutions, providing safer and more efficient payment services, and promoting Hong Kong's vision of becoming a cashless society.About Payment Cards Group (“PCG")The Payment Cards Group Limited (“PCG”) is an innovative and leading payment technology company with operations in Singapore, Hong Kong and the Asia-Pacific region. Established in 2016, PCG has become an acquirer with principal memberships in all major card schemes and e-wallet networks. Yedpay, a member of PCG, has firmly established itself as a digital payment acceptance business in Hong Kong. Meanwhile, A3A, another member of PCG, has developed a cloud-native payment processing platform that operates through RESTful APIs, significantly reducing costs and streamlining complex processes while providing users with real-time transaction data and insights. As an acquiring processor, PCG serves as the backbone infrastructure of the entire payment industry by its Asia’s 1st cloud-based processing and settlement platform. Rooted in Hong Kong with a global vison, PCG seeks to empower merchants with cutting-edge payment technology solutions and drive high-quality development in the global payment ecosystem. For more information, please visit PCG’s website: https://www.yedpay.com/en/For media enquiries, please contact:The Payment Cards Group LimitedAlice SiuEmail: alice.siu@a3a.globalTel: (852) 9192 8145 AJA (IR and Communications)Avy YuEmail: avy.yu@ajacapital.com.hkTel: (852) 9500 4443Eudice LawEmail: eudice.law@ajacapital.com.hkTel: (852) 9326 1113 Copyright 2025 ACN Newswire via SeaPRwire.com.

PHILADELPHIA, PA, May 16, 2025 - (ACN Newswire via SeaPRwire.com) - TruMerit™ (formerly CGFNS International) welcomed the release this week of the World Health Organization's State of the World's Nursing Report, which provides the first comprehensive assessment of global nursing since the COVID-19 pandemic.TruMeritThe report highlights a critical imperative to strengthen global nursing capacity in the wake of the pandemic and amid economic uncertainty, climate change impacts, and persistent health inequities. It warns that the global health workforce shortage will continue to widen, reaching 11 million by 2030, thereby requiring a fundamental shift in how countries approach healthcare workforce planning and investment.While emphasizing the urgent need to address this challenge, TruMerit President and CEO Dr. Peter Preziosi, who served on the WHO steering committee that helped guide the report's preparation, pointed to opportunities to leverage the power of nursing to resolve inequities and shore up healthcare delivery and quality around the world."In response to this report, non-governmental organizations in the healthcare sector must adopt collaboration as their watchword and work with each other and with professional societies and patient-centered organizations in pursuing genuine social impact," said Preziosi. "We need to support next-generation approaches that recognize the critical role of nurses - who make up the largest segment of the global healthcare workforce - in advancing primary care, resilient health systems, and universal health coverage solutions to optimize population health in every country.""As the report points out, nearly 80% of the world's nurses are working in countries that cover only half the world's population. This is a critical imbalance in the global nursing workforce that must be addressed. We can help do that with a greater focus on scaling up high-quality nursing education and career development that expands across borders to enable nurses everywhere to deliver on their potential," he added.Preziosi also noted these opportunities highlighted in the report:Progress in the expansion of nurse-led care models, with more than 60% of countries now having introduced Advanced Practice Nursing. By enhancing localized, specialized care, these models are proven to deliver cost-effective care and offer a way forward in expanding health coverage and healthcare equity.The nursing profession globally is becoming more skilled and prepared, with 80% of the world's nurses now at the "professional" level. The challenge ahead, said Preziosi, is to ensure they have opportunities to work at the full extent of their education, which requires regulatory frameworks to be strengthened and modernized to reflect updated scopes of practice and relevant continuing professional development.The wider use of digital health tools is bringing expert consultations to remote areas, including those powered by telehealth and artificial intelligence. These are showing great promise in enhancing accessibility and bridging gaps in care delivery, invigorating nursing education, and improving efficiency, accessibility, and outcomes.Seizing on these and other opportunities highlighted in the report, Preziosi expressed optimism that the grave challenges posed by the nursing shortage and other factors can be addressed."When the people who deliver the care are empowered with the knowledge, tools, and inspiration to achieve excellence in their profession, they can lead the way to resolving the healthcare challenges of today and tomorrow," he said.Click here to access the WHO State of the World's Nursing report.About TruMeritTruMerit is a worldwide leader in healthcare workforce development. Formerly known as CGFNS International, the organization has a nearly 50-year history supporting the career mobility of nurses and other healthcare workers - and those who license and hire them - by validating their education, skills, and experience as they seek authorization to practice in the United States and other countries. As TruMerit, this mission has been expanded to building workforce capacity that meets the needs of people in a rapidly evolving global health landscape. Through its Global Health Workforce Development Institute, the organization is advancing evidence-based research, thought leadership, and advocacy in support of healthcare workforce development solutions, including globally recognized practice standards and certifications that will enhance career pathways for healthcare workers.Contact InformationDavid St. Johndstjohn@trumerit.orgSOURCE: TruMeritRelated Images Copyright 2025 ACN Newswire via SeaPRwire.com.

BALI, INDONESIA, May 16, 2025 - (ACN Newswire via SeaPRwire.com) - Elizaveta Babanova's debut book, "Zen and Stilettos," has sold approximately 100,000 copies since its release, securing a spot in her publisher's top-10 bestsellers list in its first year.Market analysts report that the book, which combines spiritual practices with practical business advice, has resonated with readers seeking to balance material success with personal development, particularly among professional women aged 30-45."When I achieved what once felt impossible—discovering my purpose—I forged a path forward," Babanova said in a recent interview. "At its core is my mission: to help others rediscover their soul's intention, reconnect deeply with their essence, and live a multifaceted, fulfilling life."Industry experts attribute the book's commercial success to its practical approach to spirituality in an increasingly complex business environment. Nielsen BookScan data indicates a 23% growth in the personal development category over the past year, with spiritual business guides showing particular strength."I spent years searching for meaning," said Babanova, who holds a background in finance before transitioning to writing and entrepreneurship. "It's striking how much of the external world seems designed to disconnect us from our true selves."According to published reports, Babanova's second book, "The Best Year of My Life," has also achieved bestseller status. Both titles have maintained strong sales momentum through traditional retail and e-commerce platforms.The author has leveraged her literary success to develop additional creative ventures, including the "Path of the Soul" music series, featuring music composed by Elizaveta and performed by Tchaikovsky and Gnesin Conservatories graduates. The concerts have been staged in Bali and the United Arab Emirates. This spring, "Path of the Soul" concerts will be performed in Damanhur, Italy and Moscow, Russia."Through books, music, broadcasts, and writing, I share my inner state," Babanova explained. "Those who resonate with it form a natural, deep connection. There's no greater joy than helping others unlock their divine potential—it fulfils my own purpose."Market analysts note that Babanova's success represents a growing trend of merging traditional business principles with holistic approaches to personal development. Her ability to translate spiritual concepts into commercially viable products has positioned her as a notable figure.In addition to her writing and music, Babanova operates Mystic Travel, which organises retreats to locations she describes as sacred "places of power." "For most of my adult life I have been called to places on Earth that hold sacred codes," Babanova said of the travel venture. "They're like haute cuisine: you can follow a Michelin-starred chef's recipe, but it's never the same as tasting their dish in their kitchen. Similarly, documentaries and books can't rival the visceral transformation of being in these spaces. Their energy expands and reshapes you," said the world traveler, who has spent time in over 45 countries.The diversified business model has proven effective, with revenue streams from book sales, concert tickets, retreat packages, and merchandise contributing to overall growth. Industry analysts project continued expansion as Babanova's brand gains international recognition.According to publisher announcements, her forthcoming book, "Dance in Abundance," will be released in 2025 and will deeply explore universal codes of abundance, including ancient initiation traditions and their modern applications. An English-language edition is being prepared for international distribution."I have deeply immersed myself in the study of the ancient practice of initiation," Babanova said regarding her upcoming work. "During one of my own, I received an insight about crafting a line of sacred artefacts. In ancient times, every significant initiation was marked by a special object—a symbol of transformation that amplified a person's desired qualities."That insight led to developing a pearl jewellery brand that combines natural elements with spiritual symbolism, adding another dimension to her business portfolio.According to social media analytics firm Socialblade, the author maintains active social media channels with over 500,000 combined followers across platforms, where she shares content related to personal growth and business development."Creative expression became my way of sharing profound inner states," Babanova said. "Books, albums, and concerts flowed naturally from what I felt. Words alone couldn't capture the depth of those emotions, so I turned to music and performance to convey unconditional love and the joy of existence."Market research firm BookScan reports that the success of "Zen and Stilettos" has helped drive a 15% increase in the spiritual business advice subcategory over the past fiscal year. The book has been particularly successful in Moscow, St. Petersburg, and Yekaterinburg, with growing interest in international markets.Literary critics have noted the book's accessibility despite addressing complex philosophical concepts. The Russian Publishers Association recognised the work in its annual report as an example of effectively bridging practical business advice with personal development principles."Every project starts as a personal need—to experience and express life as something magnificent and eternal. Then it finds its audience, resonating with those meant to connect with it," Babanova explained her creative process.According to development partners, the author plans to launch a mobile application called "World of Abundance" later this year. The application will feature daily practices and support resources for her tribe.Babanova's rise in the publishing industry follows a broader trend of increasing consumer interest in integrated approaches to business success and personal fulfilment. Global market research firm Ipsos reports that 67% of professionals consider spiritual well-being important to their career development.Media contactBrand: Eliza BabanovaContact: Eliza BabanovaWebsite: https://elizavetababanova.com Copyright 2025 ACN Newswire via SeaPRwire.com.

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - May 15, 2025) - Euro Manganese Inc. (TSXV: EMN) (ASX: EMN) (FSE: E060) (the "Company" or "EMN") is pleased to announce that shareholders have voted in favour of all matters of business brought before them at the Company's Annual General & Special Meeting of Shareholders (the "Meeting") held on May 15, 2025. Detailed results of the voting from the Meeting are set out below.In addition, the Company announces an upcoming change to its Chief Financial Officer effective at the end of the month. See below for details.In respect of Resolution 1, election of the Company's directors, all five management nominees standing for election were elected as set out below based on a vote conducted by ballot:NomineeTotal Votes CastVotes For% ForVotes Withheld (Abstained)% Withheld (Abstained)John Webster35,504,22930,473,63485.835,030,59514.17David B. Dreisinger35,504,22930,289,60185.315,214,62814.69Thomas M. Stepien35,504,22930,298,60185.345,205,62814.66Ludivine Wouters35,504,22933,904,00495.491,600,2254.51Rick Anthon35,618,22933,735,88894.721,882,3415.28 The following matters of business at the Meeting, which were also carried out and decided by ballot, were approved: Total VotesVotes For% ForVotes Against% AgainstVotes Withheld/AbstainedResolution 2 - Appointment of Pricewaterhouse- Coopers LLP as Auditors of the Company35,645,59931,760,22489.10N/AN/A3,885,375Resolution 3 -Re-approval of the Company's Stock Option Plan (1)35,504,22932,389,65791.232,963,7028.35150,870 (1) In accordance with the rules of the Australian Securities Exchange (the "ASX"), shareholders of the Company also approved the Company's stock option plan by a majority of the votes cast, with the 455,661 votes cast by directors of the Company excluded and reclassified as withheld/abstain. Based on this exclusion and reclassification, the total number of votes cast in respect of this resolution was 35,504,229, of which 31,933,996 votes were cast for the resolution, representing 89.94% of the total votes cast, 2,963,702 votes were cast against the resolution, representing 8.35% of the total votes cast, and 606,531 votes were withheld/abstain, representing 1.71% of the total votes cast.Additionally, for purposes of the ASX, shareholders of the Company also approved each of the following resolutions:a) for the purpose of Listing Rule 7.1 of the ASX, the issuance of 21,400,000 Units comprising of 21,400,000 Shares and 21,400,000 Warrants to the European Bank for Reconstruction and Development (the "EBRD") and the issuance of up to 18,063,331 Units comprising of 18,063,331 Shares and 18,063,331 Warrants, and 14,650,278 Units comprising of 14,650,278 CHESS Depositary Interests ("CDIs") each representing one Share and 14,650,278 Warrants to sophisticated and professional investors, respectively, (the "Offering");b) for the purpose of Listing Rules 10.11.1 and 10.11.4 of the ASX, the issuance to the following individuals of Units under the Offering on terms and conditions identical to all other subscribers under the Offering:(i) 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to JJW Investments Ltd., a company controlled by Mr. John Webster;(ii) 41,666 Units, comprising of 41,666 Shares and 41,666 Warrants, to Dr. David B. Dreisinger.(iii) 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Mr. Thomas M. Stepien.(iv) 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Ms. Ludivine Wouters; and(v) 256,410 Units, comprising of 256,410 CDIs and 256,410 Warrants, to Mr. Rick Anthon;c) for the purpose of Listing Rule 7.1 of the ASX, the issuance of 4,904,478 broker warrants (the "Broker Warrants") to Canaccord Genuity (Australia) Limited ("Canaccord") and Foster Stockbroking Pty Ltd. ("FSB"), in connection with their remuneration for acting as co-lead managers of the Offering;d) for the purpose of Listing Rule 7.1 of the ASX, the issuance of 7,692,307 CDIs and 7,692,307 Warrants to Eligible Shareholders under the Share Purchase Plan ("SPP") on the terms and conditions described in the prospectus issued to Eligible Shareholders; ande) for the purpose of Listing Rule 7.1 of the ASX, the issuance of 22,263,733 Orion Warrants to OMRF (BK) LLC ("Orion") as compensation for certain amendments to the Convertible Loan and Royalty Agreement.In accordance with Listing Rule 3.13.2(d) of the ASX, detailed results of the voting from the Meeting, on the resolutions outlined above, all of which were carried out and decided by ballot, are set out below. Total VotesVotes For% ForVotes Against% AgainstVotes Withheld /AbstainedResolution 4(a) - Issuance of 54,113,609 Units comprising 39,463,331 Shares and 14,650,278 CDIs and 54,113,609 Warrants to Non-Related Party Investors and the EBRD35,504,22927,456,33777.33%1,228,2963.46%6,819,596Resolution 4(b)(i) - Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to JJW Investments Ltd.35,504,22933,171,67093.431,235,0523.481,097,507Resolution 4(b)(ii) - Issuance of 41,666 Units, comprising of 41,666 Shares and 41,666 Warrants, to Dr. David B. Dreisinger35,504,22933,187,96793.481,235,0523.481,081,210Resolution 4(b)(iii) - Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Mr. Thomas M. Stepien35,504,22933,407,64994.091,235,0523.48%861,528Resolution 4(b)(iv) - Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Ms. Ludivine Wouters35,504,22933,196,67893.501,234,1883.481,073,363Resolution 4(b)(v) - Issuance of 256,410 Units, comprising of 256,410 CDIs and 256,410 Warrants, to Mr. Rick Anthon35,504,22933,469,60294.27%1,234,1883.48800,439Resolution 4(c) - the issuance of 4,904,478 Broker Warrants to Canaccord and FSB35,504,22930,898,39487.03%1,163,4983.28%3,442,337Resolution 4(d) - the issuance of 7,692,307 CDIs and 7,692,307 Warrants to Eligible Shareholders under the SPP35,504,22933,324,73093.86%906,0862.55%1,273,413Resolution 5 - the issuance of 22,263,733 Orion Warrants to Orion35,504,22933,362,54693.97%1,184,9243.34%956,759 The Company disregarded the following votes, from the applicable resolutions, as required by Listing Rule 14.11 of the ASX:a) votes cast by the EBRD or any person (or any associates of such person) who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issuance of Shares or CDIs under the Offering (except a benefit solely by reason of being a holder of ordinary shares in the Company) from Resolution 4(a);b) votes cast by any person (or any associates of such person) who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issuance of securities under the Offering (except a benefit solely by reason of being a holder of ordinary shares in the Company) from Resolutions 4(b)(i), 4(b)(ii), 4(b)(iii), 4(b)(iv);4(b)(v) and 4(c);c) votes cast by Canaccord and FSB (or any associates of Canaccord and FSB) who will be receiving Broker Warrants (except a benefit solely by reason of being a holder of ordinary shares in the Company) from Resolution 4(c);d) votes cast by any person (or any associates of such person) who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issuance of securities under the SPP (except a benefit solely by reason of being a holder of ordinary shares in the Company) from Resolution 4(d); ande) votes cast by Orion (or any associates of Orion) or any person (or any associates of such person) who will be receiving Orion Warrants (except a benefit solely by reason of being a holder of ordinary shares in the Company) from Resolution 5.Accordingly, the following voting exclusions applied to each of the resolutions below as required by the rules of the ASX:Resolution 4(a): Total votes for Resolution 4(a) exclude 6,527,532 votes cast by parties participating in the Offering, including the EBRD and the directors. The excluded votes are reclassified to votes withheld/abstain, resulting in no change to the total Shares being voted in connection with Resolution 4(a).Resolution 4(b)(i): Total votes for Resolution 4(b)(i) exclude 235,979 votes cast by John Webster (and entities controlled by him, including JJW Investments Ltd.) who subscribed for Units in the Offering. The excluded votes are reclassified to votes withheld/abstain, resulting in no change to the total Shares being voted in connection with Resolution 4(b)(i).Resolution 4(b)(ii): Total votes for Resolution 4(b)(ii) exclude 219,682 votes cast by David Dreisinger (and entities controlled by him) who subscribed for Units in the Offering. The excluded votes are reclassified to votes withheld/abstain, resulting in no change to the total Shares being voted in connection with Resolution 4(b)(ii).Resolution 4(b)(iii): Total votes for Resolution 4(b)(iii) exclude nil votes cast by Thomas Stepien (and entities controlled by him) who subscribed for Units in the Offering.Resolution 4(b)(iv): Total votes for Resolution 4(b)(iv) exclude nil votes cast by Ludivine Wouters (and entities controlled by her) who subscribed for Units in the Offering.Resolution 4(b)(v): Total votes for Resolution 4(b)(v) exclude nil votes cast by Rick Anthon (and entities controlled by him) who subscribed for Units in the Offering.Resolution 4(c): Total votes for Resolution 4(c) exclude 2,390,000 votes cast by Canaccord and FSB, or their associates, which are to be issued Broker Warrants. The excluded votes are reclassified to votes withheld/abstain, resulting in no change to the total Shares being voted in connection with Resolution 4(c).Resolution 4(d): Total votes for Resolution 4(d) exclude 468,854 votes cast by parties participating in the SPP. The excluded votes are reclassified to votes withheld/abstain, resulting in no change to the total Shares being voted in connection with Resolution 4(d).Resolution 5: Total votes for Resolution 5 exclude nil votes cast by Orion which is to be issued Orion Warrants.A total of 35,504,229 common shares, representing approximately 44.09% of the issued and outstanding common shares of the Company eligible to vote at the Meeting, were voted in connection with all of the above resolutions, except for the following: (a) the election of the Mr. Rick Anthon as a director of the Company, for which 35,618,229 common shares, representing approximately 44.23% of the issued and outstanding common shares of the Company eligible to vote at the Meeting were voted; and (b) resolution 2, the appointment of PricewaterhouseCoopers LLP as Auditors of the Company, for which 35,645,599 common shares, representing approximately 44.26% of the issued and outstanding common shares of the Company eligible to vote at the Meeting were voted. The results of all matters considered at the Meeting are reported in the Report of Voting Results as filed by the Company on SEDAR at www.sedarplus.ca.In accordance with ASX Listing Rule 3.13.2(e), the information below is being provided for the aggregate number of securities for which valid proxies were received before the Meeting. None of the Company appointed proxy holders were able to vote on any of the resolutions in their discretion.NomineeTotal Proxies ReceivedProxy directed to vote ForProxy directed to voteAgainstProxy directed toAbstainProxy could vote at theirdiscretionResolution 1 - Election of directors:     John Webster35,504,22930,473,634N/A5,030,595NilDavid B. Dreisinger35,504,22930,289,601N/A5,214,628NilThomas M. Stepien35,504,22930,298,601N/A5,205,628NilLudivine Wouters35,504,22933,904,004N/A1,600,225NilRick Anthon35,618,22933,735,888N/A1,882,341NilResolution 2 - Appointment of Pricewaterhouse- Coopers LLP as Auditors of the Company35,645,59931,760,224N/A3,885,375NilResolution 3 - Re-approval of the Company's Stock Option Plan (1)35,504,22931,933,9962,963,702606,531NilResolution 4(a) - Issuance of 54,113,609 Units comprising 39,463,331 Shares and 14,650,278 CDIs and 54,113,609 Warrants to Non-Related Party Investors and the EBRD(2)35,504,22927,456,3371,228,2966,819,596NilResolution 4(b)(i) - Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to JJW Investments Ltd. (3)35,504,22933,171,6701,235,0521,097,507NilResolution 4(b)(ii) - Issuance of 41,666 Units, comprising of 41,666 Shares and 41,666 Warrants, to Dr. David B. Dreisinger(4)35,504,22933,187,9671,235,0521,081,210NilResolution 4(b)(iii) - Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Mr. Thomas M. Stepien35,504,22933,407,6491,235,052861,528NilResolution 4(b)(iv) - Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Ms. Ludivine Wouters35,504,22933,196,6781,234,1881,073,363NilResolution 4(b)(v) - Issuance of 256,410 Units, comprising of 256,410 CDIs and 256,410 Warrants, to Mr. Rick Anthon35,504,22933,469,6021,234,188800,439NilResolution 4(c) - the issuance of 4,904,478 Broker Warrants to Canaccord and FSB(5)35,504,22930,898,3941,163,4983,442,337NilResolution 4(d) - the issuance of 7,692,307 CDIs and 7,692,307 Warrants to Eligible Shareholders under the SPP(6)35,504,22933,324,730906,0861,273,413NilResolution 5 - the issuance of 22,263,733 Orion Warrants to Orion35,504,22933,362,5461,184,924956,759Nil (1) Excludes 455,661 votes cast by proxy by directors of the Company, which were reclassified as withheld/abstain.(2) Excludes 6,527,532 votes cast by proxy by the EBRD, directors and other subscribers in the Offering, which were reclassified as withheld/abstain.(3) Excludes 235,979 votes cast by proxy by John Webster and companies controlled by him (including JJW Investments Ltd.), which were reclassified as withheld/abstain.(4) Excludes 219,682 votes cast by proxy by David Dreisinger and companies controlled by him, which were reclassified as withheld/abstain.(5) Excludes 2,390,000 votes cast by proxy by Canaccord and FSB or their associates, which were reclassified as withheld/abstain.(6) Excludes 468,854 votes cast by proxy by subscribers to the SPP, which were reclassified as withheld/abstain. Change in Chief Financial OfficerThe Company also announces that Dean Larocque will step down as Chief Financial Officer effective May 30, 2025. The Company would like to thank Dean for his efforts since joining the Company in November 2024 and wish him well in his future endeavours. The Company expects to announce the appointment of its new Chief Financial Officer in the coming weeks.About Euro ManganeseEuro Manganese is a battery materials company focused on becoming a leading producer of high-purity manganese for the electric vehicle industry. The Company is advancing development of the Chvaletice Manganese Project in the Czech Republic and an early-stage opportunity to produce battery-grade manganese products in Bécancour, Québec.The Chvaletice Project is a unique waste-to-value recycling and remediation opportunity involving reprocessing old tailings from a decommissioned mine. It is also the only sizable resource of manganese in the European Union, strategically positioning the Company to provide battery supply chains with critical raw materials to support the global shift to a circular, low-carbon economy.Euro Manganese is dual-listed on the TSXV and the ASX.Authorized for release by the President and CEO of Euro Manganese Inc.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) or the ASX accepts responsibility for the adequacy or accuracy of this release.InquiriesMartina BlahovaPresident and CEO  +1-604-681-1010 ext. 101Website: www.mn25.caLaurel PetrykChief Legal Officer & Corporate Secretary+1-604-681-1010LodeRock AdvisorsNeil WeberInvestor and Media Relations - North America+1 (647) 222-0574 neil.weber@loderockadvisors.comJane Morgan Management Jane Morgan Investor and Media Relations - Australia +61 (0) 405 555 618 jm@janemorganmanagement.com.auCompany Address: #709 -700 West Pender St., Vancouver, British Columbia, Canada, V6C 1G8Forward-Looking StatementsCertain statements in this news release constitute "forward-looking statements" or "forward-looking information" within the meaning of applicable securities laws. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the Company, its Chvaletice Project, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as "may", "would", "could", "will", "intend", "expect", "believe", "plan", "anticipate", "estimate", "scheduled", "forecast", "predict" and other similar terminology, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.Readers are cautioned not to place undue reliance on forward-looking information or statements. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements and, even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company.Forward-looking statements include statements regarding replacing the Chief Financial Officer and any expected outcome and ability to navigate current market conditions. All forward-looking statements are made based on the Company's current beliefs including various assumptions made by the Company, including that the Chvaletice Project will be developed and operate as planned, the Company will obtain sufficient financing, and that the Company will be able to meet the conditions of its secured financing. Factors that could cause actual results or events to differ materially from current expectations include, among other things: insufficient working capital; inability to meet the conditions of its secured financing, risks due to granting security, lack of availability of financing for developing and advancing the Chvaletice Project; the potential for unknown or unexpected events to cause contractual conditions to not be satisfied; developments in EV (Electric Vehicles) battery markets and chemistries; risks related to fluctuations in currency exchange rates; and regulation and changes in laws by various governmental agencies. For a further discussion of risks relevant to the Company, see "Risk Factors" in the Company's annual information form for the year ended September 30, 2024, available on the Company's SEDAR+ profile at www.sedarplus.ca.Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release and are expressly qualified in their entirety by this cautionary statement. Subject to applicable securities laws, the Company does not assume any obligation to update or revise the forward-looking statements contained herein to reflect events or circumstances occurring after the date of this news release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/252349 Copyright 2025 ACN Newswire via SeaPRwire.com.

West Palm Beach, FL, May 15, 2025 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official brand of the United States Polo Association (USPA), is proud to announce its launch in the Argentine market alongside its brand partners Incom S.p.a. and Sur Pacifico S.A. This entry further enhances the multi-billion-dollar brand's global presence and expands U.S. Polo Assn.'s reach into another new and exciting market.U.S. Polo Assn.The global sports brand's presence in Argentina will focus on a territory steeped in history, where the sport of polo is not only widely celebrated but also deeply rooted in the local culture. U.S. Polo Assn. will commence with the launch of the men's collection in June 2025, featuring timeless styles such as polo shirts, woven shirts, t-shirts, trousers, jeans, knitwear, and jackets."Partnering with Incom S.p.a. and Sur Pacifico S.A. to bring the U.S. Polo Assn. brand to Argentina for the first time-a country with a profound polo legacy and amazing consumers-is a significant milestone," said J. Michael Prince, President and CEO of USPA Global, the company that manages and oversees the multi-billion-dollar global U.S. Polo Assn. brand. "This opportunity has the potential for U.S. Polo Assn. to be one of the most influential sport-inspired brands in the entire marketplace."Sur Pacifico S.A. is an Argentine company founded in 1985. With a solid business and brand background, it has established itself in the textile clothing market, initially focusing on men's and children's apparel and more recently expanding to women's fashion. Since 1992, Sur Pacifico S.A. has been the exclusive licensee of the Mistral brand, a Dutch-origin brand originally linked to water sports, particularly surfing. The company also manages two international brands, Brooksfield and Royal Einfield Apparel."We are thrilled to have found a strategic partner in Argentina, such as Sur Pacifico S.A., who aligns with our values, allowing us to bring the U.S. Polo Assn. brand to a market historically connected to the sport of polo," says Lorenzo Nencini, CEO of Incom. "This unique collaboration will allow us to reach new, passionate consumers and strengthen U.S. Polo Assn.'s authentic connection within the world of sports, creating a perfect synergy between the brand's heritage and the excellence of this discipline in Argentina."ABOUT U.S. POLO ASSN.U.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and based at the USPA National Polo Center in Wellington, Florida. This year, U.S. Polo Assn. celebrates 135 years of sports inspiration alongside the USPA. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. Historic deals with ESPN in the United States and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, NBA, and MLB, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global and digital growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world.For more information, visit uspoloassnglobal.com and follow @uspoloassn.ABOUT INCOM S.P.A.Incom S.p.a., founded in Montecatini Terme (PT) in 1951, operates under license as the clothing division of the U.S. Polo Assn. brand and also produces and distributes important clothing brands worldwide. Additionally, Incom S.p.a. is one of the main suppliers of military and paramilitary clothing for the Italian State, providing both uniforms and technical apparel made with the special proprietary patent "Float" for floating garments. Since January 2008, Incom S.p.a. has been producing and distributing men's, women's, children's, underwear, and swimwear clothing under the U.S. Polo Assn. brand in Europe, with consistently growing sales results. For more information, visit www.incomitaly.com.Contact InformationPaola VaraniHUB PRESS OFFICEpaolavarani@hubcomm.netLaura VaraniHUB PRESS OFFICElauravarani@hubcomm.netStacey KovalskyVP, Global PR and Communications, USPA Globalskovalsky@uspagl.com+001.561.790.8036Alesia LanaMarketing & Communications, Incom S.p.a.a.lana@incomitaly.comCamilla DonatiHUB PRESS OFFICEcamilladonati@hubcomm.netSOURCE: U.S. Polo Assn. Copyright 2025 ACN Newswire via SeaPRwire.com.

- The 5th Asia Summit on Global Health launches new Silver Health Chapter, focusing on innovations in anti-ageing and enhancing healthcare for the elderly.- The 16th Hong Kong International Medical and Healthcare Fair serves as a comprehensive platform to foster global collaborations, attracting some 300 exhibitors to showcase cutting-edge medical technologies, gerontechnology and green solutions.HONG KONG, May 15, 2025 - (ACN Newswire via SeaPRwire.com) – The fourth International Healthcare Week (IHW), coordinated by the Hong Kong Trade Development Council (HKTDC), will take place from 26 May to 15 June. The IHW’s flagship events, the Asia Summit on Global Health (ASGH), jointly organised by the HKSAR Government and HKTDC, will be held at the Hong Kong Convention and Exhibition Centre (HKCEC) on 26 and 27 May while the Hong Kong International Medical and Healthcare Fair (Medical Fair), organised by the HKTDC and co-organised by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA), will run concurrently from 26 to 28 May, highlighting Hong Kong’s position as a leading regional healthcare hub.Margaret Fong, Executive Director of the HKTDC, said: “As a global hub for medical innovation, Hong Kong serves as both a ‘super-connector’ and a ‘super value-adder’, driving regional collaboration to advance healthcare innovation and foster new quality productivity in biopharmaceutical technologies. At the same time, there are pressing global public health challenges, such as an ageing population and the rising prevalence of chronic diseases, which are intensifying healthcare demand. To address these challenges, the industry is actively embracing innovative technologies to upgrade and transform the healthcare sector. This year’s ASGH introduces a dedicated Silver Health Chapter, with both ASGH and the Medical Fair highlighting healthy ageing and elderly health innovations. The HKTDC will continue to serve as a platform for cross-sector collaboration supporting industry-academia-research partnership in fields including biotechnology, digital healthcare, and smart elderly wellness. We look forward to bringing together local and global experts, investors, enterprises, and institutions through ASGH and Medical Fair, injecting new vitality into the Asian healthcare industry and shaping the future of the medical sector.”Global expertise shapes the future of healthcareThemed Fostering Global Collaboration for a Shared Future, the 5th ASGH reaffirms Hong Kong’s pivotal role as a leading MedTech hub in the region. Through diverse elements such as the ASGH Business Hub, ASGH connects global healthcare innovators, investors, and project owners on a single platform, acting as a catalyst for potential partnerships. Government officials and organisations, research pioneers, investors, and business leaders from the global healthcare sector will also share insights on industry trends and explore collaboration opportunities among Hong Kong, Mainland China, and global enterprises in healthcare investment and innovation.Dr Peter K N Lam, Chairman of the HKTDC, will deliver welcome remarks, while John Lee, Chief Executive of the HKSAR will give opening remarks, and Prof Cao Xuetao, Vice-Minister of the National Health Commission of the People’s Republic of China, will give special remarks on the first day of ASGH.The first session of the ASGH Plenary Sessions will commence on the opening day and focus on building a more equitable and sustainable healthcare system and explore how innovative policymaking and strengthened international collaboration can foster healthcare systems that are both resilient and inclusive to address emerging global health challenges.  Prof Lo Chung-mau, HKSAR Government’s Secretary for Health, will deliver the special remarks and will be joined by an esteemed panel of speakers, including Prof Tsui Lap-chee, Chairman of the University of Hong Kong Foundation for Educational Development and Research; Prof Nancy Ip, President of the Hong Kong University of Science and Technology; Mr Frédéric Rimattei, Special Envoy for International Affairs of the President of French University Hospitals National Association; Dr Wu Xiaobin, Vice President of China Pharmaceutical Innovation and Research Development Association; and Mr Martin Taylor, Representative to China of World Health Organisation.At the second plenary, speakers will examine how global stakeholders can collaborate to navigate the current economic and healthcare innovation landscape while identifying new investment and market opportunities in the health sector. The session will be chaired by Mr Victor Chu, Chairman & CEO of First Eastern Investment Group, featuring Ambassador George Hara, Group Chairman and CEO of DEFTA Partners; Prof Ng Siew-chien, Croucher Professor in Medical Sciences and Associate Dean (Research) of Faculty of Medicine of the Chinese University of Hong Kong; Dr Hiroaki Ueno, Representative Director of Mitsubishi Tanabe Pharma Corporation and Dr Prem Kumar Nair, Group Chief Executive Officer of IHH Healthcare Berhad.During the Dialogue with Global Pioneer in Health session, Prof John Hardy, Chair of Molecular Biology of Neurological Disease of UCL Queen Square Institute of Neurology, will share his insights on his groundbreaking work on emerging therapeutic approaches to neurodegenerative diseases. Prof Hardy was awarded the Breakthrough Prize and received the Brain Prize for "groundbreaking research on the basis of Alzheimer's disease”.Inaugural Silver Health Chapter: Navigating ageing's challenges & opportunitiesAmidst the global demographic shift toward ageing populations, this year's ASGH proudly inaugurates a dedicated "Silver Health Chapter" aimed at critically examining the multifaceted challenges and transformative opportunities presented by ageing societies. On the second day, a session titled Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology, will bring together experts including Prof Jean Woo, Director of CUHK Jockey Club Institute of Ageing of the Chinese University of Hong Kong; Dr Donald Li, Chairman of Elderly Commission; Dr Alexandra Bause, Co-Founder & Venture Partner of Apollo Health Ventures; Mr Olivier Dessajan, General Manager of China Merchants Colisée; Prof James L. Kirkland, Director of Center for Advanced Gerotherapeutics of Cedars-Sinai; and Dr Sanja Tomovska, Founder and CEO of Quant Biomarkers. This distinguished assembly will present groundbreaking developments in geroscience, while critically evaluating emerging investment paradigms within the global longevity economy.On the same day, global industry leaders will convene for a dedicated session titled The Next Wave of Innovations in Neuroscience, examining cutting-edge advancements and emerging trends in neurological science, including novel therapeutic approaches for Parkinson's disease and related disorders. Concurrently, the InnoHealth Showcase will feature healthcare investment projects specifically designed to address the needs of ageing populations, presenting data-driven approaches to mitigate the challenges of demographic ageing.During ASGH, Ms Anita Ou, Managing Director and Head of Enterprise Banking of HSBC; Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and Chief Executive Officer of Gleneagles Hospital Hong Kong; Prof Zhang Weixiong, Associate Director of Academy for Interdisciplinary Research (PAIR) of The Hong Kong Polytechnic University; Dr Sarah Salvilla, Group Chief Health Officer of FWD Group, will share their insights on achieving "Healthy China 2030," the high quality development of the healthcare industry, data-driven healthcare, and new collaborative models for the healthcare sector. ASGH will also address trending topics in the healthcare industry, including the prospects of gene and cell therapies, women's health, the convergence of Chinese and Western medicine, cancer treatment, orphan drugs, and rare diseases.ASGH, in collaboration with the Hong Kong University of Science and Technology, will host two sessions under the overarching theme “Shaping the Future of Healthcare”. These sessions will focus on the potential of artificial intelligence in the medical field and how innovative technologies can drive breakthroughs in healthcare. Featured speakers include Dr Alex Ng, President of Tencent Healthcare; Prof Graham Cooke, Vice-Dean (Research) of the Faculty of Medicine of Imperial College London; Prof Chen Hao and Prof Bonnie Zhu, Assistant Professors of the Hong Kong University of Science and Technology.ASGH deal-making bridges investors and project ownersThe ASGH deal-making facilitates one-on-one meetings both online and offline, aiming to connect investors and projects in the healthcare sector from around the world to promote global collaborations. Participating investors represent a diverse range of backgrounds, including angel investors, venture capital, corporate venture capital, private equity, family offices and more. Investment interests span pharmaceuticals, medical devices and diagnostics, AI and digital health, and community health and wellness.The ASGH Business Hub features more than 170 innovative technology companies from 13 countries and regions, including dedicated pavilions from the mainland (Shanghai and Xiamen), Australia, and Thailand. The InnoHealth Showcase area highlights more than 70 healthcare start-ups and projects, many of which have received awards, and is led by the Innovation and Technology Commission in collaboration with six local universities and Cyberport.Medical Fair facilitates industry collaborationThemed as the Innovations Boosting Smart Health Experience, the 16th Medical Fair will be held from 26 to 28 May, and welcomes some 300 exhibitors from 13 countries and regions. In addition to pavilions and exhibitors from Hong Kong, Mainland China, Taiwan, Japan, Korea and Hungary, there are also pavilions from Israel, Thailand, and the United Kingdom participating for the first time, along with debut exhibitors from Germany, Italy, Luxembourg and Singapore..The Medical Fair serves as an excellent platform for professionals worldwide, encompassing research and development institutions, manufacturers, public healthcare organisations, hospitals, clinics, distributors, and healthcare practitioners. This event facilitates the establishment of global business connections and provides valuable insights into the latest trends in the healthcare industry. The exhibition features the HKMHDIA Pavilion, as well as Biotechnology, Hospital Equipment, Rehabilitation and Elderly Care Products, and Startup zones.This year's Medical Fair highlights three major areas: cutting-edge medical technologies, gerontechnology, and green solutions, featuring the latest medical health devices, products, and applications, with a particular emphasis on medical diagnostics, innovations in smart hospitals, and digital health solutions.One exhibitor will showcase a solution that uses advanced computer vision and artificial intelligence to analyse data from patients with facial paralysis and swallowing difficulties. By matching patients with the most suitable rehabilitation programmes from a database of more than 400 training exercises, the solution provides therapists personalised treatment suggestions to refine and adopt. Another exhibitor introduces medical-grade digital therapy solutions for cognitive impairments, leveraging AI to assess patient conditions and deliver customised rehabilitation programs. Further innovations include a handheld medical device for cervical examinations, which analyses cervical tissue to aid in the detection and prevention of preterm births.The Hong Kong Council of Social Service will make its inaugural participation at the Medical Fair, presenting age-friendly technologies and products including rehabilitation and mobility aids, cognitive impairment support systems, and smart home innovations. Additionally, other exhibitors will showcase sustainable products, such as eco-conscious eating bibs crafted from recycled plastic bottles and biodegradable medical trays.The Medical Fair features a strong line-up of leading research and academic institutions, including seven local universities, over 30 innovative technology companies at the Hong Kong Science and Technology Parks Corporation (HKSTP) pavilion, and more than 20 medical enterprises brought by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA). The event will actively promote innovation and collaboration across government, industry, academia, research and investment sectors.Multiple activities will be held during the Medical Fair to help industry professionals expand their knowledge of the latest market information. The HKMHDIA Medical Fair Forum themed “The MedTech Nexus of the Greater Bay Area” features industry experts sharing their insights on topics such as intellectual property protection strategies for biomedical innovation, cross-border financial solutions for medical enterprises, the development of cross-border health data, and successful experiences in promoting medical technology in the Greater Bay Area. “The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area” seminar will bring together representatives from the Greater Bay Area Center for Medical Device Evaluation and Inspection of the National Medical Products Administration, the Department of Health, and industry leaders to discuss the latest developments, administrative systems, and regulations.Using the HKTDC EXHIBITION+ hybrid model, the physical fair from 26 to 28 May is complemented by the Click2Match smart business matching platform, via which buyers can extend their sourcing journey from 19 May to 4 June.Aside from ASGH and the Medical Fair, IHW also features the Hospital Authority Convention, among many other industry events.Asia Summit on Global HealthDate26-27 May 2025 (Monday to Tuesday)TimeThe Opening Session will begin at 10:00 am on 26 MayVenueHong Kong Convention and Exhibition Centre (HKCEC) Hall 5FGHong Kong International Medical and Healthcare FairDate26-28 May 2025 (Monday to Wednesday)VenueHong Kong Convention and Exhibition Centre (HKCEC) Hall 3FGPhoto download: https://bit.ly/3F1aoFpThe Asia Summit on Global Health held last year was a great successProf John Hardy, Chair of Molecular Biology of Neurological Disease of UCL Queen Square Institute of Neurology, is one of the featured keynote speakers at the Asia Summit on Global HealthThe ASGH Business Hub features more than 170 innovative technology companies, including more than 70 healthcare start-ups and projects led by the Innovation and Technology Commission, Cyberport, and six local universities, many of which have received awardsThis year’s Hong Kong International Medical and Healthcare Fair has attracted some 300 exhibitors from 13 countries and regions. The Medical Fair marks the debut participation of exhibitors from Singapore, Germany, Italy and Luxembourg, as well as debut pavilions from Israel, Thailand, and the United Kingdom. The picture shows the bustling scene from the Fair last yearThis year’s Medical Fair features the HKMHDIA Pavilion, as well as Biotechnology, Hospital Equipment, Rehabilitation and Elderly Care Products, and Startup zonesWebsitesInternational Healthcare Week: https://internationalhealthcareweek.hktdc.com/enAsia Summit On Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/enProgramme: https://www.asiasummitglobalhealth.com/conference/asgh/en/programmeSpeakers: https://www.asiasummitglobalhealth.com/conference/asgh/en/speakerHong Kong International Medical and Healthcare Fair:https://www.hktdc.com/event/hkmedicalfair/enList of products: https://www.hktdc.com/event/hkmedicalfair/en/productActivity schedule: https://www.hktdc.com/event/hkmedicalfair/en/intelligence-hubMembers of the media interested in interviewing ASGH speakers, please send requests to tleung@yuantung.com.hk on or before 20 May 2025Media enquiriesFor enquiries, please contact Yuan Tung Financial Relations Limited:Louise SongTel: (852) 3428 5691Email: lsong@yuantung.com.hkTiffany LeungTel: (852) 3428 2361Email: tleung@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Asia Summit on Global HealthSharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgKaty WongTel: (852) 2584 4524Email: katy.ky.wong@hktdc.orgJane CheungTel: (852) 2584 4137Email: jane.mh.cheung@hktdc.orgHong Kong International Medical and Healthcare FairKelly ShekTel: (852) 2584 4537Email: kelly.yt.shek@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgMedia Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.  Copyright 2025 ACN Newswire via SeaPRwire.com.

MELBOURNE, May 14, 2025 - (ACN Newswire via SeaPRwire.com) - With geopolitical tensions, inflation uncertainty, and global capital flows still shifting in response to the Trump administration's renewed sanctions, fixed income continues to emerge as the strategic asset class for long-term investors. Quotient Capital Pty Ltd has released its 2025 mid-year outlook, showcasing how Australian fixed income is delivering security, stability, and consistent real returns in a turbulent global environment.Australian Fixed Income: A Beacon of Stability in Volatile MarketsGlobal markets have been shaken by widespread sanctions introduced by the second Trump administration, prompting turbulence across equities, commodities, and even traditional safe havens. Yet Australia's fixed income market remains a pillar of strength.The Reserve Bank of Australia (RBA) forecasts inflation to moderate toward the 2-3% target range by late 2025. Coupled with Australia's sound credit environment, strong institutional frameworks, and fiscal stability, this positions the domestic bond market as one of the most attractive globally.Key research insights from Quotient Capital include:Australian private credit grew by 14% year-on-year (2024-2025).Domestic corporate bond issuance surged 22% in Q1 2025.Liquidity across the investment-grade bond market is at its strongest in over a decade."Fixed income is no longer just a defensive allocation - it's a proactive, yield-focused wealth strategy," said Tom McCallister, Senior Fixed Income Advisor at Quotient Capital."In this cycle, investors are demanding capital protection, income certainty, and inflation resilience - and Australian bonds deliver all three."Geopolitical Shifts and Global Capital ReallocationThe global ripple effects of U.S. sanctions have disrupted cross-border capital flows and credit availability across multiple regions - driving a recalibration among asset allocators.Australia is benefitting as a preferred destination for investors seeking:Political neutralityRobust regulatory governanceHigh-grade credit assets"Private wealth, family offices, and institutions are reallocating to Australia with growing conviction," said James Harrington, Senior Fixed Income Advisor at Quotient Capital."We offer a unique mix of economic resilience and institutional-grade product access, which is proving incredibly attractive."Bringing Institutional Access to Private InvestorsQuotient Capital bridges the gap between institutional-grade opportunities and private capital - making it possible for high-net-worth individuals and SMSFs to access premium fixed income products, previously restricted to larger funds.Tailored solutions include:Infrastructure-linked debt instrumentsInflation-linked corporate bond portfoliosPrivate credit notes focused on essential service sectorsAll offerings are underpinned by detailed credit analysis, transparent structuring, and clear maturity horizons. Minimum investments typically start at $50,000 AUD.Strategic Outlook: Where the Smart Capital Is Going in 2025Continued demand for floating-rate notes (FRNs) as inflation hedgesGrowth in infrastructure and essential services-backed bondsRising private investor flows into corporate and hybrid debt marketsSMSFs and family offices driving long-term allocations toward predictable yield strategies"In today's macro climate, fixed income isn't a side allocation anymore - it's the core of the modern portfolio," McCallister adds.About Quotient CapitalQuotient Capital Pty Ltd is a privately-owned wealth advisory firm based in Melbourne, Australia. Specialising in fixed income and private market strategies, the firm empowers sophisticated investors - including SMSFs, family offices, and high-net-worth individuals - with direct access to institutional-grade opportunities backed by deep research, transparency, and personalised advisory.Office Address:Collins Square Tower 5, 727 Collins Street, Melbourne VIC 3008Phone: +61 3 9111 2441Email: info@quotient-capital.comWebsite: www.quotient-capital.comMedia ContactFor interviews, commentary, or speaker engagements on global fixed income, Australian credit markets, or private debt access:Media Enquiries: pr@quotient-capital.comPhone: +61 3 9111 2441SOURCE: Quotient Capital Pty Ltd Copyright 2025 ACN Newswire via SeaPRwire.com.

- Offer price of S$0.25 per share is at an attractive premium of 61.3% over the last traded price being 9 May 2025 and the 12-month volume-weighted average price- The Partial offer provides Cordlife shareholders an opportunity to exit at a premium- Medeze views this as a strategic opportunity to invest with long-term intent and explore collaborations with Cordlife including promotion of services together for market expansion, products/services development, diversification of business in the region and cost and operational synergiesSingapore / Bangkok, May 13, 2025 - (ACN Newswire via SeaPRwire.com) - Thailand-listed Medeze Group Public Company Limited (“Medeze”, together with its subsidiaries, the “Medeze Group”), through its wholly owned subsidiary Medeze Treasury Pte. Ltd. (the “Offeror”), intends to make a voluntary conditional cash partial offer (the “Partial Offer”) to acquire 10.00% of the issued ordinary shares of Cordlife Group Limited (“Cordlife” or the “Offeree”), a Singapore-listed provider of cord blood banking services. The move signals Medeze’s first strategic step into the Singapore market, with the intention of exploring business opportunities with the Offeree to create long-term value and mutual benefit for both parties.Terms of the Partial OfferUnder the terms of the Partial Offer, the Offeror is seeking to acquire 25,630,774 shares, equivalent to 10.00% of Cordlife’s total issued and paid-up ordinary shares (excluding treasury shares) (the “Shares”), at an offer price of S$0.25 per share (the “Offer Price”). This represents an attractive premium of approximately 61.3% to the last traded price of S$0.155 on 9 May 2025, and also the 12-month volume-weighted average price.The Partial Offer will be subject to the minimum acceptance condition of the Offeror having received, by the close of the Partial Offer, valid acceptances and/or tenders in respect of not less than 25,630,774 Shares, representing 10.00% of the total number of Shares (excluding treasury shares) as at the Record Date. The Partial Offer will not become or be capable of being declared unconditional in all respects unless the above condition is satisfied.The Partial Offer represents an attractive opportunity for Cordlife shareholders to realise part or potentially all of their investment. Based on the Offeror’s observation that the Shares of the Offeree has been thinly traded in recent years, the Offer Price reflects a healthy premium over recent trading levels.Rationale of the Partial OfferThe Partial Offer, if successful, will allow the Offeror to increase its direct holdings (including the existing shares held by the Offeror) in the Offeree to approximately 10.68% of the total number of Shares (excluding treasury shares) as at the Record Date. Upon successful completion of the Partial Offer, the Offeror, together with Medeze, will communicate with and endeavour to explore business opportunities with the Offeree to create long-term value and mutual benefit for both parties.The Offeror wishes to demonstrate its commitment to contribute positively to the Offeree as a long-term substantial shareholder. By acquiring a meaningful stake, the Offeror aims to collaborate with existing controlling shareholders and management to drive sustainable value creation for all stakeholders. The Offeror believes in engaging in constructive dialogue and partnership with existing shareholders and management to align on strategic priorities, governance, and operational enhancements that will benefit the Offeree’s long-term success.If a collaboration eventuates, Medeze Group and Cordlife could provide services to each other’s customers which helps to strengthen the market position and network of Medeze Group and Cordlife.  As an example and for illustrative purposes only, Medeze Group could (where permissible), offer services like analyzing and storing NK cell and hair follicle banking services to Cordlife’s customers. Cordlife (where permissible) could on the other hand offer its chromosomal and genetic analysis and screening services to Medeze Group’s customers. This collaboration can further support the growth of both Medeze Group and Cordlife at the international level.The Medeze Group recorded total revenue of THB 874.3 million and net profit of THB 338.7 million, representing growth of 23.6% and 41.4% year-on-year respectively. Medeze Group’s asset base more than tripled to over THB 3.4 billion, following its successful listing of the Stock Exchange of Thailand and strategic reinvestment into technology and capacity.About MedezeThe Medeze Group has been in business for more than 14 years and is a leader in the Southeast Asia stem cell storage and services market.Recognised as the Southeast Asia Stem Cell Banking Company of the Year by Frost & Sullivan for two consecutive years (2023 and 2024), the Medeze Group has a laboratory that is accredited by the Association for the Advancement of Blood and Biotherapies (AABB) from the United States. The laboratory is equipped with modern equipment and technology in the stem cell banking industry, such as AutoXpress and Quantum Machine.The Medeze Group is founded and headed by the incumbent chief executive officer, Dr. Veerapol Khemarangsan, an experienced Obstetrics and Gynecology specialist, who brings deep clinical and commercial expertise. He continues to be personally involved in stem cell procedures, lending Medeze Group a rare combination of medical and operational leadership. He currently serves as the Director of Training Committee in Bangkok Metropolitan Endoscopic Center (BMEC).For more information of the Medeze Group, please: https://www.medezegroup.com/th/.About CordlifeCordlife was incorporated in Singapore on 2 May 2001 and has been listed on the Mainboard of the Singapore Exchange Securities Trading Limited (“SGX-ST”) since 29 March 2012. The Offeree is a group company in the business of providing cord blood banking services such as the collection, processing, testing, cryopreservation and storage of umbilical cord blood at birth in countries including Singapore, Hong Kong, Macau, Indonesia, Thailand, India and the Philippines.For media queries, please contact:ThailandInvestor RelationsMedeze GroupDID: +66 91 599 9999 (press 2)Email: ir@medezegroup.comSingaporeTevinder SinghAssociateFinancial PRDID: +65 6438 2990Email: tevinder@financialpr.com.sg The directors of the Offeror (including any director who may have delegated detailed supervision of the preparation of this document) have taken all reasonable care to ensure that the facts stated and opinions expressed in this document are fair and accurate and that no material facts have been omitted from this document, and they jointly and severally accept responsibility accordingly.Where any information has been extracted or reproduced from published or otherwise publicly available sources or obtained from the Offeree, the sole responsibility of the directors of the Offeror has been to ensure through reasonable enquiries that such information is accurately extracted from such sources or, as the case may be, reflected or reproduced in this document. Copyright 2025 ACN Newswire via SeaPRwire.com.